This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Harvard College. Active years: 1995-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2000
Title: The Innovative Contributions of Andrew Luster
Introduction
Andrew Luster is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of biotechnology, particularly in cancer research. With a total of 4 patents to his name, Luster's work focuses on the therapeutic applications of cytokines in treating neoplasms.
Latest Patents
Luster's latest patents include groundbreaking methods for utilizing the cytokine IP-10 as an anti-tumor agent. One of his notable patents describes methods and therapeutic compositions for inhibiting neoplasms through the administration of a nucleic acid sequence encoding the IP-10 polypeptide. Another patent outlines the use of the cytokine IP-10 in treating neoplasms by administering the polypeptide IP-10 or a suitable DNA vector encoding the polypeptide.
Career Highlights
Andrew Luster is affiliated with Harvard College, where he continues to advance research in the field of cancer therapeutics. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
Luster has collaborated with esteemed colleagues, including Philip Leder, to further enhance the impact of his research. Their combined expertise has contributed to the development of novel therapeutic strategies.
Conclusion
Andrew Luster's contributions to cancer research through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile